Order Article Reprints

Matsumae T, Kodama T, Tahata Y, Myojin Y, Doi A, Nishio A, Yamada R, Nozaki Y, Oshita M, Hiramatsu N, et al. Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral. Cancers. 2023; 15(2):463. https://doi.org/10.3390/cancers15020463

Matsumae, Takayuki, Takahiro Kodama, Yuki Tahata, Yuta Myojin, Akira Doi, Akira Nishio, Ryoko Yamada, Yasutoshi Nozaki, Masahide Oshita, Naoki Hiramatsu, and et al. 2023. "Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral" Cancers 15, no. 2: 463. https://doi.org/10.3390/cancers15020463

Matsumae, T., Kodama, T., Tahata, Y., Myojin, Y., Doi, A., Nishio, A., Yamada, R., Nozaki, Y., Oshita, M., Hiramatsu, N., Morishita, N., Ohkawa, K., Hijioka, T., Sakakibara, M., Doi, Y., Kakita, N., Yakushijin, T., Sakamori, R., Hikita, H., ... Takehara, T. (2023). Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral. Cancers, 15(2), 463. https://doi.org/10.3390/cancers15020463